Kerr Drug is a clinical research site located in Chapel Hill, North Carolina, United States 27517.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Kerr Drug has participated in 1 clinical trials.
Therapeutic areas: Stroke, Transient Ischemic Attack, Myocardial Infarction.
Sponsors: University of North Carolina, Chapel Hill.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Kerr Drug has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Kerr Drug has 1 clinical trials on record. Their work covers Stroke, Transient Ischemic Attack, Myocardial Infarction.
Kerr Drug has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.